A carregar...
Mutant IDH1: An immunotherapeutic target in tumors
The discovery of driver mutations in cancers has raised interest in their suitability as immunotherapeutic targets. A recent study demonstrates that a point mutation in isocitrate dehydrogenase 1 (IDH1R132H), expressed in gliomas and other tumors, is presented on human MHC class II and induces a mut...
Na minha lista:
| Publicado no: | Oncoimmunology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4353168/ https://ncbi.nlm.nih.gov/pubmed/25964867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.974392 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|